NLE Endocrine & Metabolic Nursing — Adrenal DisordersSummary

Cortisol is the primary glucocorticoid hormone secreted by the adrenal cortex in response to ACTH (adrenocorticotropic hormone) released by the anterior pituitary. The hypothalamus releases CRH (corticotropin-releasing hormone), which stimulates ACTH secretion. A **negative-feedback loop** controls this axis: when blood cortisol is high, it suppresses both CRH and ACTH; when cortisol is low, the axis is activated to raise cortisol. Cortisol has a **diurnal (circadian) rhythm**, with peak levels in the early morning (6-8 AM) and lowest levels at midnight. This rhythm is disrupted in Cushing's syndrome. Cortisol functions to raise blood glucose, suppress immunity and inflammation, promote protein and fat catabolism, and prepare the body for stress. Understanding the HPA axis is essential because **exogenous corticosteroid therapy suppresses the pituitary-adrenal response**, and sudden withdrawal leaves patients unable to produce cortisol during stress—a critical teaching point for preventing adrenal crisis.

Aldosterone is the primary mineralocorticoid, produced by the **zona glomerulosa** of the adrenal cortex. Unlike cortisol (regulated by ACTH), aldosterone is primarily regulated by the **renin-angiotensin-aldosterone system (RAAS)** in response to low blood pressure or low sodium, and by **serum potassium levels**. Aldosterone's mechanism of action is to **increase sodium reabsorption and potassium excretion in the distal tubules of the nephron**, thereby **increasing blood volume and blood pressure** while promoting **hypokalemia**. Aldosterone deficiency (as in Addison's disease) causes **sodium loss, water loss, potassium retention, and hypotension**. Aldosterone excess (as in primary hyperaldosteronism/Conn's syndrome) causes **sodium and water retention, potassium loss, and hypertension**. This hormone is critical to understanding the electrolyte derangements characteristic of adrenal disorders.

The adrenal medulla (inner core) is essentially a specialized sympathetic nerve plexus that secretes **epinephrine (adrenaline)** and **norepinephrine (noradrenaline)** in response to sympathetic stimulation (not ACTH). These catecholamines are the hormones of the 'fight-or-flight' response: they increase heart rate and force of contraction (beta-1 effect), increase blood pressure (alpha-1 vasoconstriction), increase blood glucose (beta-2), cause sweating, dilate pupils, and mobilize metabolic energy. A pheochromocytoma is a catecholamine-secreting tumor of the medulla that causes **paroxysmal (episodic) severe hypertension, headache, diaphoresis, and palpitations**. Understanding medullary physiology is essential for recognizing pheochromocytoma and understanding why alpha-blockade must precede beta-blockade.

Cushing's syndrome is a clinical syndrome of **chronic glucocorticoid excess** resulting from either exogenous (long-term corticosteroid therapy—the most common cause) or endogenous sources (pituitary ACTH-secreting adenoma, adrenal tumor, or ectopic ACTH production). The **manifestations of excess cortisol** mirror the hormone's physiological effects: **truncal/central obesity with thin extremities** (fat is mobilized from limbs and deposited centrally), **moon facies** (facial fullness), **buffalo hump** (dorsocervical fat pad), **thin, fragile skin prone to bruising** (collagen breakdown), **purple striae** (stretch marks), **hirsutism and acne** (excess androgens), **muscle wasting and weakness** (protein catabolism), **osteoporosis** (calcium loss), and **immunosuppression** (masked infection signs). The **hyperglycemia** (cortisol raises glucose), **hypertension and fluid retention** (mineralocorticoid effect), and **hypokalemia** (mineralocorticoid excess) are characteristic. The loss of **diurnal variation** (elevated cortisol at all hours) is a diagnostic hallmark. Mood changes, psychosis, and impaired wound healing are common. The clinical presentation reflects both the direct effects of cortisol and the metabolic consequences of prolonged excess.

Addison's disease (primary adrenal insufficiency) is a condition of **chronic cortisol and aldosterone deficiency** resulting from destruction or dysfunction of the adrenal cortex. The most common cause in developed nations is **autoimmune** destruction; in the Philippines and other endemic areas, **tuberculosis** is a significant cause. **Secondary adrenal insufficiency** results from **pituitary ACTH deficiency** (e.g., pituitary tumor, surgery, or apoplexy) or **tertiary insufficiency** from **hypothalamic CRH deficiency**. The clinical manifestations are the **mirror image of Cushing's**: **hypotension** (aldosterone deficiency → sodium/water loss), **hyponatremia and hyperkalemia** (reduced aldosterone and lack of cortisol-induced sodium retention), **hypoglycemia** (low cortisol cannot raise glucose), **weight loss and anorexia**, **fatigue and weakness**, **nausea, vomiting, diarrhea**, **depression**, and the pathognomonic **hyperpigmentation** (in primary Addison's, the loss of negative feedback on the anterior pituitary leads to very high ACTH levels, which stimulate melanin production → bronze/tan skin, darkened nipples, and oral mucosa). **Salt craving** is common. The **ACTH stimulation test** (giving synthetic ACTH) helps differentiate primary (cortisol fails to rise) from secondary/tertiary (cortisol rises) insufficiency. The diagnosis is life-changing because **lifelong replacement therapy is mandatory**, and **any acute stressor can precipitate an adrenal crisis**.

An **adrenal crisis** (also called Addisonian crisis) is an **acute, life-threatening state of severe cortisol and aldosterone deficiency** precipitated by major physiological stress (infection, trauma, surgery, myocardial infarction) in a patient with undiagnosed or undertreated adrenal insufficiency, or by **sudden withdrawal of long-term corticosteroid therapy**. The pathophysiology reflects the sudden inability to meet the cortisol demand of stress: **profound hypotension leading to hypovolemic shock** (due to aldosterone deficiency and cortisol's role in maintaining vascular tone), **severe hyponatremia and hyperkalemia** (sodium loss, potassium retention), **severe hypoglycemia** (cortisol cannot raise glucose), **high fever and profuse vomiting/diarrhea/dehydration**, and **potential vascular collapse and death** if untreated. The **PRIORITY management** is: **(1) immediate IV hydrocortisone (100 mg bolus, then continuous infusion or repeated doses)**—this is the life-saving intervention; **(2) rapid IV fluid replacement with normal saline (NS) containing 5% dextrose** to correct hypovolemia, hyponatremia, and hypoglycemia simultaneously; **(3) continuous monitoring of vital signs, electrolytes, glucose, and cardiac rhythm**; **(4) treatment of hyperkalemia** if severe (insulin + glucose, calcium gluconate, beta-agonists, diuretics); and **(5) identification and treatment of the precipitating stressor**. This is a **never-miss diagnosis** in the context of hypotensive, hypoglycemic, hyperkalemic patients, especially those with recent steroid withdrawal or known Addison's disease.

A **pheochromocytoma** is a usually benign (90%), catecholamine-secreting neuroendocrine tumor of the **adrenal medulla** (or occasionally of extra-adrenal chromaffin tissue—paraganglioma). The tumor releases **episodic surges of epinephrine and norepinephrine**, causing the **classic triad of severe HEADACHE, PALPITATIONS (with tachycardia), and profuse DIAPHORESIS** (sweating). The **paroxysmal (episodic) HYPERTENSION**—often dangerously elevated (e.g., 180-220+ mmHg systolic)—is a hallmark; some patients are normotensive between episodes. Additional manifestations include **tremor, anxiety, chest or abdominal pain, flushing, pallor, and hyperglycemia**. Episodes can be triggered by physical activity, abdominal palpation (critical—**do not palpate the abdomen**), Valsalva maneuver, certain foods (tyramine-rich foods like aged cheeses, cured meats), and medications (sympathomimetics, tricyclic antidepressants). **Diagnosis** relies on **elevated plasma free metanephrines or 24-hour urine metanephrines/VMA** (vanillylmandelic acid); the 24-hour urine requires **avoidance of caffeine, bananas, and certain medications** (phenothiazines, decongestants, some antidepressants) to prevent false elevation. **Imaging** (CT/MRI) localizes the tumor. **Management** is **surgical adrenalectomy**, but **critical pre-operative preparation** involves: **(1) ALPHA-BLOCKADE FIRST (phenoxybenzamine or doxazosin) for at least 10-14 days** to expand the depleted intravascular volume and prevent a hypertensive crisis; only after adequate alpha-blockade is achieved, **(2) BETA-BLOCKERS (propranolol) if tachycardia persists**. **NEVER give a beta-blocker first or alone**—unopposed alpha-adrenergic stimulation causes a life-threatening hypertensive crisis. Post-operatively, patients require careful monitoring for **hypotension** (catecholamine levels drop sharply) and support with IV fluids. This condition is a differential diagnosis for resistant hypertension and sudden hypertensive episodes.

Primary hyperaldosteronism is a condition of **excess aldosterone secretion** (usually from an aldosterone-secreting adrenal adenoma, or less commonly bilateral adrenal hyperplasia) that causes **sodium and water retention, potassium loss, and metabolic alkalosis**. The classic presentation is **resistant or difficult-to-control hypertension** (due to sodium and water retention expanding plasma volume) paired with **hypokalemia** (manifesting as muscle weakness, cramps, polyuria due to hypokalemia-induced nephrogenic diabetes insipidus, and cardiac arrhythmias). Notably, **peripheral edema is often absent** despite sodium retention—the patient maintains a new steady state of hypertension without edema. **Diagnosis** involves demonstrating an elevated aldosterone-to-renin ratio, suppressed plasma renin activity, and imaging to identify an adenoma. **Management** includes **potassium-sparing diuretics (spironolactone, amiloride)** to block aldosterone's effects and correct hypokalemia, **potassium supplementation**, and **surgical adrenalectomy** for an adenoma (or medical management for bilateral hyperplasia). This condition is part of the differential diagnosis of **secondary hypertension** and is important for recognizing that hypokalemia with hypertension has a specific endocrine cause.

**Exogenous corticosteroid therapy** (prednisone, dexamethasone, hydrocortisone, methylprednisolone) is used for numerous conditions (autoimmune diseases, inflammatory disorders, allergic reactions, transplant rejection, cancer therapy), but prolonged use creates a critical problem: the **negative feedback of exogenous cortisol suppresses the hypothalamus and pituitary, leading to decreased ACTH secretion and adrenal cortex atrophy**. When the patient is stable, the exogenous steroid replaces endogenous cortisol. However, if the steroid is **abruptly withdrawn**, the patient suddenly has **no exogenous source AND an atrophied adrenal cortex unable to respond to stress**—creating the risk of **adrenal crisis**. This is why **steroids must ALWAYS be tapered slowly**, allowing the HPA axis to gradually recover and the adrenal cortex to re-expand. The risk is greatest if steroids have been given for >2-3 weeks or in high doses. **Steroid tapering protocols** typically reduce the dose gradually over weeks to months, with the tapering slowed if the patient reports fatigue, weakness, or other signs of insufficient cortisol. During acute stress (infection, surgery, trauma) while on steroids **or during tapering**, the patient requires **stress dosing** (increased steroid dose temporarily to meet the cortisol demand of stress)—a critical patient teaching point called **'sick-day rules'**. Patients must carry a **medical alert bracelet or card** indicating corticosteroid use, and should carry an **emergency injectable hydrocortisone kit** (e.g., SoluCortef) for use during unexpected severe illness or trauma.

Accurate diagnosis of adrenal disorders requires specific, targeted diagnostic tests: **(1) Serum or plasma cortisol** (measured early morning, 6-8 AM, to assess baseline and diurnal rhythm; normally 15-25 mcg/dL AM, <10 mcg/dL midnight); **(2) 24-hour urinary free cortisol** (gold standard—elevated in Cushing's; normal <50-100 mcg/24 hr depending on assay); **(3) Dexamethasone suppression test (DST)** (in normal individuals, low-dose dexamethasone 1 mg suppresses cortisol the next morning to <5 mcg/dL; in Cushing's, cortisol **fails to suppress**, or suppresses at the high dose 8 mg but not the low dose, suggesting pituitary ACTH-secreting disease); **(4) ACTH level** (high ACTH in primary adrenal disease [e.g., Addison's] or pituitary ACTH-secreting tumor; low ACTH in secondary adrenal insufficiency or adrenal tumor producing cortisol autonomously); **(5) ACTH stimulation test** (synthetic ACTH [cosyntropin] is given IV; in a normal or secondary insufficiency patient, cortisol rises; in primary Addison's, cortisol **fails to rise** because the cortex is destroyed); **(6) 24-hour urine metanephrines or VMA** (for pheochromocytoma diagnosis; patient must avoid caffeine, bananas, aged cheeses, cured meats, and certain medications for 3 days before collection); **(7) Plasma free metanephrines** (alternative to urine test for pheochromocytoma, higher sensitivity); **(8) Serum electrolytes** (sodium, potassium, glucose)—**reading electrolytes alone often identifies the disorder**: Cushing's = high sodium/glucose, low potassium; Addison's = low sodium/glucose, high potassium; **(9) Imaging** (CT or MRI of abdomen/pituitary to locate the source). The choice and interpretation of tests depend on the clinical suspicion and the need to localize the lesion.

Nursing care for adrenal disorders is organized using the nursing process and NANDA-I nursing diagnoses. **Common nursing diagnoses for Cushing's syndrome include**: (1) **Risk for infection** (related to immunosuppression); (2) **Risk for injury** (related to fragile skin, osteoporosis, muscle weakness); (3) **Disturbed body image** (related to physical changes—moon face, striae, obesity); (4) **Excess fluid volume** (related to sodium and water retention); (5) **Imbalanced nutrition: more than body requirements** (related to increased appetite from steroids); (6) **Chronic low self-esteem** (related to appearance and mood changes); (7) **Ineffective coping** (related to mood disturbances and psychosis); (8) **Deficient knowledge** (related to steroid side effects and need for monitoring). **Nursing interventions** include: monitoring vital signs and blood pressure, monitoring and replacing potassium, encouraging low-sodium diet, fall prevention measures, skin care and wound care, monitoring blood glucose, psychosocial support, and education about the underlying disorder and treatment. **Common nursing diagnoses for Addison's disease include**: (1) **Risk for deficient fluid volume/Hypovolemia** (related to aldosterone deficiency); (2) **Risk for electrolyte imbalance** (specifically hyponatremia and hyperkalemia); (3) **Risk for acute adrenal crisis** (related to lack of stress response); (4) **Ineffective tissue perfusion** (related to hypotension); (5) **Activity intolerance/Fatigue** (related to cortisol deficiency and hypoglycemia); (6) **Deficient knowledge** (related to lifelong medication management, stress dosing, and sick-day rules). **Priority interventions** include: replacing fluids and electrolytes, monitoring closely for signs of crisis, administering glucocorticoid and mineralocorticoid replacement, educating the patient about strict medication adherence, teaching stress-dosing rules, and providing psychological support. **For adrenal crisis**, the top-priority diagnoses are **Shock/Deficient fluid volume**, **Electrolyte imbalance**, and **Hypoglycemia**, with immediate implementation of IV fluids, IV hydrocortisone, and continuous monitoring. Maslow's hierarchy guides prioritization: **physiological needs (airway, breathing, circulation, glucose, electrolytes) are paramount**, followed by safety, then psychosocial needs.

Patients with chronic adrenal disorders require **comprehensive, ongoing health education** to prevent complications and emergencies. **For patients on long-term corticosteroids or with Cushing's syndrome**, education includes: **(1) Never stop the steroid abruptly** (risk of adrenal crisis); **consult the physician before making any changes**; **(2) Take the steroid in the morning with food** (mimics natural cortisol rhythm, reduces insomnia and GI upset); **(3) Monitor for signs of hypokalemia** (muscle weakness, cramps, polyuria) and salt retention; **(4) Low-sodium diet**, adequate protein, calcium, and vitamin D; **(5) Fall prevention** (fragile bones, muscle weakness); **(6) Report signs of infection immediately** (fever, sore throat, wound changes) because the immune system is suppressed; **(7) Blood glucose monitoring** and recognition of hyperglycemia; **(8) Expect mood changes and report significant depression or anxiety**; **(9) Sun protection and wound care** (skin is fragile); **(10) Avoid certain medications and discuss all new medications with the physician**. **For patients with Addison's disease**, education is **life-critical**: **(1) Lifelong glucocorticoid (hydrocortisone) and mineralocorticoid (fludrocortisone) replacement—never miss doses or abruptly stop**; **(2) Sick-day rules**: increase the steroid dose (double or triple) during illness, stress, infection, or planned surgery, and continue the higher dose until the stress resolves—this is the most important teaching to prevent crisis; **(3) Recognize early signs of adrenal crisis** (severe fatigue, nausea, vomiting, diarrhea, abdominal pain, dizziness, confusion, loss of consciousness) and seek immediate emergency care; **(4) Carry a medical alert bracelet or card** at all times; **(5) Keep an emergency injectable hydrocortisone kit** (e.g., SoluCortef pen) at home, in the car, and at work; **(6) Adequate salt intake**—season food liberally, especially in hot weather or with exercise; **(7) Maintain regular follow-up appointments** and regular blood work (electrolytes, glucose, cortisol levels); **(8) Inform all healthcare providers** (dentist, surgeon, emergency room) of the Addison's diagnosis before any procedure. **For pheochromocytoma**, pre-operative and post-operative education includes: understanding the surgery, the medication regimen (alpha-then-beta-blockers), post-operative hypotension management, and lifelong follow-up (because recurrence is possible). All education should be **culturally sensitive, written and oral, with time for questions**, and reinforced at each visit.

Cushing's syndrome and Addison's disease are **pathophysiological opposites**, and the NLE frequently tests the ability to differentiate them using clinical presentation and lab values. **The contrast**: **CUSHING'S (excess cortisol)**: HIGH blood pressure (hypertension), HIGH sodium (sodium retention), **LOW potassium** (hypokalemia), **HIGH blood glucose** (hyperglycemia), WEIGHT GAIN (central/truncal obesity), **THIN skin with striae and easy bruising**, **immunosuppression (masked infection signs)**, mood elevation or psychosis, hirsutism/acne. **Lab findings**: elevated cortisol, elevated 24-hour urine free cortisol, loss of diurnal variation, high ACTH (if pituitary source) or low ACTH (if adrenal tumor). **ADDISON'S (deficiency of cortisol and aldosterone)**: **LOW blood pressure** (hypotension), **LOW sodium** (hyponatremia), **HIGH potassium** (hyperkalemia), **LOW blood glucose** (hypoglycemia), WEIGHT LOSS, **HYPERPIGMENTATION** (bronze/tan skin in primary Addison's), **salt craving**, fatigue/depression, **high ACTH** (in primary Addison's). **Lab findings**: low cortisol, low sodium, high potassium, low glucose, high ACTH (primary) or low ACTH (secondary). **Reading the electrolytes alone is often diagnostic**: a patient with **hyponatremia + hyperkalemia + hypoglycemia** is almost certainly **Addison's**; a patient with **hypokalemia + hyperglycemia + hypertension** is almost certainly **Cushing's**. This contrast is a **favorite NLE testing strategy** and is essential for differential diagnosis and rapid recognition.

**Cushing's syndrome**, if untreated or inadequately controlled, leads to serious complications: (1) **Poorly controlled hypertension and heart failure** (from chronic sodium/water retention and mineralocorticoid excess); (2) **Diabetes mellitus or exacerbation of existing diabetes** (from chronic hyperglycemia); (3) **Osteoporosis and pathologic fractures** (from cortisol-induced calcium loss); (4) **Serious infections** (from immunosuppression—pneumonia, sepsis, fungal infections); (5) **Thromboembolism** (from hypercoagulability and immobility); (6) **Hypokalemic periodic paralysis** or severe cardiac arrhythmias (from chronic hypokalemia); (7) **Cognitive decline and psychiatric complications** (from mood disturbance and chronic cortisol excess). Long-term management focuses on treating the underlying cause (tapering exogenous steroids, surgically removing a tumor, medical management of ectopic ACTH) and **monitoring and managing complications**: blood pressure control, diabetes management, bone health (calcium, vitamin D, bisphosphonates), infection prevention, and psychological support. **Addison's disease**, despite lifelong replacement therapy, carries the **ever-present risk of adrenal crisis** if the patient misses doses, encounters unexpected stress, or the replacement dose is inadequate. **Other complications include**: (1) **Chronic fatigue and activity intolerance** (from suboptimal replacement or poor adherence); (2) **Electrolyte derangements** (if the mineralocorticoid dose is not optimized); (3) **Hypoglycemia** (especially between meals or with intercurrent illness); (4) **Adrenal insufficiency during pregnancy and labor** (requiring increased steroids); (5) **Medication interactions** (certain drugs enhance steroid metabolism or affect absorption); (6) **Psychosocial burden** (living with the knowledge of a life-threatening disease and the need for lifelong medication). Long-term management of Addison's requires **regular follow-up (typically every 6-12 months), routine blood work** (electrolytes, glucose, cortisol levels if indicated), **optimization of replacement doses based on symptoms and stress**, and **reinforcement of education**. **Pheochromocytoma**, even after successful surgical removal, carries a **5-10% recurrence rate** (especially in familial syndromes), so **lifelong imaging follow-up** (annual or biennial CT/MRI) and catecholamine monitoring may be indicated. Post-operative **hypertension may persist** in some patients, and careful blood pressure management is needed. The **adrenal medulla** (if only one gland is removed) may regenerate, but if **bilateral adrenalectomy** was performed, the patient becomes **permanently Addisonian and requires lifelong glucocorticoid and mineralocorticoid replacement**.

The HPA axis is the regulatory mechanism that maintains cortisol homeostasis. Dysregulation of this axis at any level (hypothalamus, pituitary, or adrenal cortex) leads to either Cushing's syndrome (axis hyper-function or autonomous cortisol secretion) or Addison's disease (axis hypo-function or destruction of the cortex). Understanding the HPA axis explains why ACTH levels differ between primary and secondary causes and why the negative feedback loop is disrupted in Cushing's (high cortisol suppresses ACTH) but activated in Addison's (low cortisol fails to suppress ACTH, leading to very high ACTH). The loss of diurnal variation in Cushing's reflects loss of normal rhythmic ACTH pulsing.

Each physiological effect of cortisol directly explains the manifestations of its excess or deficiency. For example, cortisol's role in raising blood glucose explains hyperglycemia in Cushing's and hypoglycemia in Addison's; its role in promoting fat redistribution explains truncal obesity in Cushing's and weight loss in Addison's; its role in suppressing immunity explains infection risk in Cushing's; its role in maintaining vascular tone and blood pressure explains hypertension in Cushing's and hypotension in Addison's. Understanding the mechanism ensures the student can predict and recognize manifestations.

Aldosterone's mechanism of action (sodium reabsorption, potassium excretion) directly explains the electrolyte derangements in adrenal disorders. Aldosterone deficiency in Addison's causes hyponatremia (sodium loss) and hyperkalemia (potassium retention); aldosterone excess in primary hyperaldosteronism causes sodium and water retention (hypertension) and hypokalemia. This mechanism also explains why the electrolyte panel is a rapid diagnostic clue: electrolytes alone often reveal the diagnosis.

Long-term exogenous steroid therapy suppresses the HPA axis (negative feedback), causing ACTH to fall and the adrenal cortex to atrophy (termed 'secondary adrenal insufficiency' from long-term steroid use). If the steroid is abruptly withdrawn, the patient has no exogenous source AND an atrophied cortex unable to respond to stress, creating the risk of adrenal crisis. This causal chain explains why steroids MUST be tapered (to allow HPA axis recovery), why stress dosing is needed during taper (to meet cortisol demand), and why the patient is at risk of crisis if the dose is not adequately adjusted during stress.

Pheochromocytoma releases massive amounts of epinephrine and norepinephrine, which overstimulate alpha-1 receptors (causing vasoconstriction and severe hypertension). If a beta-blocker is given first (without alpha-blockade), the alpha-receptors remain unopposed and hyperactive, causing a life-threatening hypertensive crisis (this is called 'unopposed alpha' effect). This is why alpha-blockade MUST precede beta-blockade—the alpha-blockade prevents alpha-receptor overstimulation, allowing the beta-blocker to control heart rate and contractility safely.

Adrenal crisis involves simultaneous deficiency of cortisol AND aldosterone, leading to a cascade of physiological failures: cortisol deficiency causes hypotension, hypoglycemia, and inability to respond to stress; aldosterone deficiency causes hyponatremia and hypokalemia; the combination leads to shock, metabolic derangements, and potential vascular collapse. The multi-system nature of the crisis explains why management must be comprehensive (hydrocortisone + fluids + electrolyte management + continuous monitoring) and why it is a true emergency.

The immunosuppression in Cushing's syndrome can mask the typical signs of infection (fever, elevated WBC, local inflammation), allowing serious infections (pneumonia, sepsis) to progress silently. This mechanism explains why patients with Cushing's require vigilant nursing assessment for subtle signs of infection (patient's subjective report of malaise, slight temperature elevation, wound changes) even when traditional infection markers are absent. It also explains why the patient is at high risk and why infection prevention is a priority nursing concern.

Addison's disease involves permanent, irreversible loss of adrenal function (whether autoimmune, TB-related, or from other causes). Once the cortex is destroyed, it cannot regenerate; therefore, lifelong glucocorticoid and mineralocorticoid replacement is mandatory. However, the replacement dose must be adjusted to the patient's stress level (sick-day rules: increase dose during illness, stress, surgery) because the exogenous hormone cannot respond dynamically to stress like the normal adrenal cortex can. This mechanism explains the critical importance of patient education about adherence and stress-dosing rules—failure to adhere or to stress-dose can precipitate a life-threatening adrenal crisis.

Different diagnostic tests reveal different information and allow localization of the lesion. In Cushing's, a high ACTH level suggests a pituitary tumor (ACTH-secreting) or ectopic ACTH; a low ACTH suggests an adrenal tumor (autonomously producing cortisol, suppressing ACTH). Dexamethasone suppression helps: pituitary ACTH-secreting tumors suppress at high-dose dexamethasone (because the tumor is still somewhat responsive to hypothalamic signals), while adrenal tumors do not suppress (they are autonomous). ACTH stimulation test helps differentiate primary (cortex destroyed, no response to ACTH) from secondary insufficiency (pituitary failure, but cortex responsive to ACTH). Understanding these test relationships allows targeted diagnosis and localization.

In primary Addison's (cortex destroyed), the negative feedback of cortisol is lost, causing the pituitary to secrete very high levels of ACTH in an attempt to stimulate the destroyed cortex to produce cortisol. ACTH itself is derived from POMC (pro-opiomelanocortin), which is also the precursor of melanin-stimulating hormone (MSH). The excess ACTH (and MSH) stimulates melanocytes to produce melanin, resulting in the pathognomonic hyperpigmentation (bronze/tan skin, darkened nipples, oral mucosa, skin creases). This is unique to primary Addison's; in secondary insufficiency (pituitary failure, low ACTH), hyperpigmentation does not occur. This is why hyperpigmentation is a clinical clue to primary (vs. secondary) Addison's disease.

A 52-year-old patient presents to the outpatient clinic with gradual onset of facial fullness (moon face), central weight gain with thin arms/legs, easy bruising, and newly diagnosed hypertension. The nurse should recognize these as classic Cushing's syndrome signs. The nursing assessment should include: vital signs (likely elevated BP), skin assessment (looking for purple striae, thin skin, bruising), weight and anthropometric measurements, blood glucose (monitoring for hyperglycemia), electrolytes (expecting hypokalemia and sodium retention), mood assessment (screening for depression/psychosis), and medication history (asking specifically about long-term steroid use). If the patient is on chronic corticosteroids, the nurse should educate about tapering (never stopping abruptly) and monitoring for side effects. If the cause is endogenous, the nurse may assist with scheduling diagnostic tests (24-hour urine cortisol, dexamethasone suppression test). The nurse should also assess infection risk and implement infection-prevention measures.

A 58-year-old patient with diabetes on 20 mg daily prednisone for an autoimmune disease presents to the emergency department with severe nausea, vomiting, diarrhea, dizziness, and profound weakness. Blood pressure is 88/52 mmHg (hypotensive), serum sodium is 118 mEq/L (hyponatremia), potassium is 6.2 mEq/L (hyperkalemia), and glucose is 45 mg/dL (hypoglycemia). The patient's spouse reports that the patient stopped taking the prednisone 3 days ago because he 'felt better.' This is a classic adrenal crisis scenario (abrupt steroid withdrawal during stress from acute illness). The nurse must immediately recognize this as a CRITICAL EMERGENCY and implement: (1) establish IV access and initiate rapid fluid resuscitation with normal saline (for hypovolemia and hyponatremia); add 5% dextrose to correct hypoglycemia; (2) alert the physician for STAT IV hydrocortisone 100 mg bolus, then 50-100 mg every 6-8 hours (or continuous infusion); (3) continuous cardiac monitoring (hyperkalemia can cause arrhythmias); (4) stat blood work (electrolytes, glucose, cortisol, ACTH); (5) treatment for hyperkalemia (calcium gluconate for cardiac protection, insulin + glucose, albuterol, possibly diuretics); (6) continuous vital sign monitoring; (7) identify and treat the precipitating stressor (acute illness); (8) educate the patient once stable about NEVER stopping steroids abruptly and the importance of stress dosing during illness.

A 45-year-old patient is admitted for elective adrenalectomy due to pheochromocytoma (diagnosed by elevated 24-hour urine metanephrines). Nursing priorities pre-operatively include: (1) understanding the patient's current medications—the patient should be on ALPHA-BLOCKERS (phenoxybenzamine or doxazosin) for 10-14 days BEFORE the operation to expand depleted intravascular volume and prevent intra-operative/post-operative hypertensive crisis; (2) assessing blood pressure regularly (noting paroxysmal episodes of severe hypertension); (3) providing a calm environment (stress can trigger catecholamine release); **(4) ABSOLUTELY AVOIDING abdominal palpation** (can trigger massive catecholamine surge and hypertensive emergency); (5) educating the patient about the medication regimen and why beta-blockers cannot be given until AFTER alpha-blockade is adequate (unopposed alpha stimulation causes crisis); (6) ensuring adequate fluid and electrolyte replacement; (7) monitoring for medication side effects (alpha-blockers may cause tachycardia, fatigue, orthostatic hypotension). Intra-operatively, the surgical team will be prepared for rapid hemodynamic changes as the tumor is manipulated. Post-operatively, the nurse must monitor for HYPOTENSION (catecholamine levels drop sharply after tumor removal), maintain IV fluids, and monitor for adrenal insufficiency if both glands were removed (requiring hydrocortisone replacement). The patient should be counseled about lifelong follow-up imaging due to recurrence risk.

A 38-year-old woman is newly diagnosed with primary Addison's disease (confirmed by low 8 AM cortisol, high ACTH, positive ACTH stimulation test showing no cortisol rise). She is started on hydrocortisone 15-20 mg daily (typically 10 mg in the morning, 5 mg at noon) and fludrocortisone 0.1 mg daily. Comprehensive nursing education is essential: **(1) Medication adherence**: take hydrocortisone every day, exactly as prescribed; DO NOT miss doses or stop abruptly (can precipitate adrenal crisis); take in the morning to mimic the natural cortisol rhythm. Fludrocortisone helps retain sodium and water; take as directed. **(2) Sick-day rules (MOST CRITICAL)**: during ANY physical stress (infection, fever, diarrhea, vomiting, surgery, dental work, severe emotional stress, exercise in heat), **DOUBLE or TRIPLE the hydrocortisone dose** immediately; continue the higher dose for 24-48 hours after the stressor resolves. Examples: with a cold, increase dose immediately; with diarrhea, increase dose and replace fluids; before surgery, take increased dose before the procedure and continue during recovery; with severe trauma, go to the ER immediately. **(3) Recognize early signs of crisis**: severe fatigue, nausea, vomiting, diarrhea, abdominal pain, dizziness, confusion, or loss of consciousness—seek immediate emergency care. **(4) Carry medical alert identification**: wear a medical alert bracelet/necklace stating 'ADDISON'S DISEASE—STEROID DEPENDENT' at all times; carry a medical alert card in the wallet. **(5) Emergency kit**: keep an injectable hydrocortisone kit (e.g., SoluCortef Emergency Kit) at home, in the car, and at work; teach the patient and a family member how to administer it (IM or IV injection) in case of crisis when she cannot take oral medication. **(6) Diet**: maintain adequate salt intake—salt food liberally, especially in hot weather or during exercise; monitor for signs of inadequate salt (salt craving, weakness, dizziness). **(7) Regular follow-up**: keep appointments for blood work (electrolytes, glucose, cortisol levels if indicated) every 6-12 months or as directed; report symptoms of under-replacement (fatigue, weakness) or over-replacement (tremor, insomnia, acne). **(8) Inform healthcare providers**: tell ALL doctors, dentists, and healthcare workers about the Addison's diagnosis before any procedure or new medication. **(9) Psychosocial support**: acknowledge the burden of lifelong medication and the ever-present risk of crisis; connect with support groups if available; address fears and ensure the patient feels confident in self-management. The nurse should provide written materials, repeat education over multiple visits, and assess understanding before discharge.

A 55-year-old patient undergoes bilateral adrenalectomy for Cushing's syndrome caused by a pituitary ACTH-secreting adenoma. The adrenalectomy removes the excessive cortisol source, but it also removes BOTH adrenal glands, making the patient permanently dependent on steroid replacement. Post-operatively, the nurse must: **(1) Monitor for hemorrhage**: the adrenal glands are highly vascular and adjacent to the inferior vena cava and renal vessels; check dressing for excessive bleeding or swelling; monitor vital signs for signs of hemorrhagic shock (tachycardia, hypotension, pale/clammy skin); report any concerning findings immediately. **(2) Manage steroid replacement**: large IV doses of hydrocortisone are given peri-operatively (stress dosing); these are typically tapered over several days as the acute post-operative stress resolves. Monitor for signs of both EXCESS steroids (even higher hyperglycemia, mood changes) and DEFICIENCY (hypotension, weakness, hypoglycemia) as the dose is adjusted. **(3) Monitor vital signs closely**, especially **blood pressure** (watch for hypotension if steroid dose is too low, or elevated BP if dose is still high). **(4) Blood glucose monitoring**: post-operative hyperglycemia may temporarily improve as cortisol excess resolves, but the patient may require insulin adjustments. **(5) Electrolytes and I&O**: monitor sodium, potassium, and fluid balance; adjust IV fluids based on urine output and serum electrolytes. **(6) Pain management**: pain increases cortisol demand, so manage pain effectively; increased steroid doses may be needed if pain is severe. **(7) Infection prevention**: even though the Cushing's-related immunosuppression is resolving, the post-operative patient is still at risk; use sterile dressing changes and monitor the surgical wound. **(8) Prevent thromboembolic complications**: administer DVT prophylaxis (sequential compression devices, early mobilization, heparin if indicated); monitor for signs of thrombosis. **(9) Assess for adrenal insufficiency symptoms**: weakness, hypotension, dizziness; report these immediately as they indicate insufficient steroid replacement. **(10) Education before discharge**: explain that the patient now requires LIFELONG steroid replacement (since both adrenal glands are removed); emphasize that steroids must be tapered gradually over weeks (not stopped abruptly), that sick-day rules apply, that a medical alert bracelet is needed, and that regular follow-up and blood work are essential. Explain that for approximately 6-12 months after **unilateral** adrenalectomy (if only one gland was removed), the remaining gland may be suppressed and slow to recover, so replacement may still be needed temporarily.

Two patients present to the clinic with different presentations. **Patient A** (age 60): complains of weight gain, new-onset hypertension, muscle weakness, and easy bruising over the past year. Labs: sodium 148 mEq/L (high), potassium 3.1 mEq/L (LOW), glucose 156 mg/dL (high), cortisol 32 mcg/dL (high). **Patient B** (age 45): complains of weight loss, dizziness, weakness, nausea, and salt craving for the past 6 months. Labs: sodium 118 mEq/L (LOW), potassium 6.5 mEq/L (HIGH), glucose 62 mg/dL (low), cortisol 3 mcg/dL (LOW), skin shows bronze/tan hyperpigmentation. The nurse's rapid differential diagnosis (based on clinical presentation and electrolytes): **Patient A = CUSHING'S SYNDROME** (weight gain, hypertension, muscle weakness, easy bruising, HIGH sodium/glucose, LOW potassium, elevated cortisol). **Patient B = ADDISON'S DISEASE** (weight loss, dizziness, weakness, nausea, salt craving, hyperpigmentation, LOW sodium/glucose, HIGH potassium, low cortisol). The nurse would then anticipate appropriate workup (Patient A: 24-hour urine free cortisol, dexamethasone suppression, ACTH level, imaging; Patient B: ACTH level [expected to be high], ACTH stimulation test, imaging). This practical application demonstrates how the nurse can use clinical assessment and lab values to rapidly recognize and differentiate these mirror-image disorders—a core NLE skill.

A 50-year-old patient with systemic lupus erythematosus (SLE) has been on prednisone 15 mg daily for 3 years to control disease activity. The nurse's role in long-term monitoring includes: **(1) Monitor for Cushing's syndrome signs**: assess weight, blood pressure, skin (looking for striae, bruising, thinning), mood, and muscle strength at each visit. **(2) Blood glucose and diabetes screening**: order fasting glucose and HbA1c annually; educate about diet and exercise to prevent steroid-induced diabetes. **(3) Bone health**: order DEXA scan to assess for osteoporosis; ensure adequate calcium (1200 mg daily) and vitamin D (800-1000 IU daily); consider bisphosphonates if osteoporosis is detected. **(4) Infection prevention**: teach signs of infection (reminder: they may be masked by immunosuppression—subtle fever, vague malaise); encourage vaccinations (influenza, pneumonia) as appropriate; educate about when to seek care. **(5) Blood pressure monitoring**: check BP at each visit; manage hypertension with diet, exercise, and antihypertensives if needed. **(6) Lipid profile**: steroids increase lipid levels; check lipids annually; manage with diet and medications if indicated. **(7) Eye exams**: steroids increase risk of cataracts and glaucoma; recommend annual ophthalmology exams. **(8) Mental health assessment**: screen for mood disturbances (steroid-induced psychosis is rare but serious); educate about signs and when to report. **(9) Medication review**: discuss all new medications with the patient; some drugs interact with steroids (reducing efficacy or increasing side effects). **(10) Steroid dose optimization**: work with the prescriber to use the LOWEST effective dose and to taper if possible; educate the patient that dose should never be stopped abruptly. **(11) Steroid education reinforcement**: at each visit, reinforce that steroids are life-saving for the SLE but carry risks; emphasize the importance of adherence, the prohibition on abrupt discontinuation, and the need for stress dosing during illness.